History

Gold Leaf Awards History

Prior to 2008, BIOTECanada's annual awards program was known as the National Biotechnology Awards with recognition for companies and individuals in four categories:

• Biotech Company of the Year
• Contribution to Advancing the Benefits of Biotech for Canadians
• Promising Early Stage Company(s) Recognition
• Contribution to the association

This page honours past recipients of our awards program.

2001- 2009 Past Award Recipients

Biotech Company of the Year

2009 - Arius Research Inc.
2008 - BioMS Medical Corp
2007 - Theratechnologies Inc.,
2006 - Aspreva Pharmaceuticals
2005 - SemBioSys Genetics Inc.
2004 - Angiotech Pharmaceuticals, Inc.

Industry Leadership Award*

2009 - Natalie Dakers, Centre for Drug Research and Development
2008 - Dr. John Evans, MaRS
2007 - Ray Mowling, Council for Biotechnology Information (Canada)
2006 - Dr. Alex McPherson, Biomira
2005 - Theresa Kennedy, Hill & Knowlton Canada
2004 - Peter McCann, President of Ag-West Bio Inc. (Retired)
2003 - J. Mark Lievonen, President, Aventis Pasteur
2002 - Gord Surgeoner, President, Ontario Agri-Food Technologies
2001 - Burleigh Trevor-Deutsch, Bioethicist, Burleigh Trevor-Deutsch Consulting
*From 2001 -2007 this award was called the "Contribution to Advancing the Benefits of Biotech for Canadians"

Early Stage Company of the Year (Health and Industrial & Agriculture)*

2009 - Medicago Inc. (Health)
2009 - Zymeworks Inc. (industrial & Agriculture)
2008 - Xenon Pharmaceuticals (Health),
2008 - Lignol Energy Corp. (Industrial & Agriculture)
2007 - Chemaphor Inc.
2007 - Technologie Biolactis
2006 - Rimon Therapeutics Ltd.
2006 - MBEC Bioproducts
2005 - ImmunoVaccine Technologies Inc., Halifax, NS
2005 - Performance Plants, Kingston, ON
2005 - Trillium Therapeutics Inc., Toronto, ON
2004 - Arc Pharmaceuticals Inc, Vancouver, BC
2004 - Clera Inc., Toronto, ON
2004 - Generex Biotechnology, Toronto, ON
2003 - GB Therapeutics (now CITA Neuropharma Inc.), Mississauga, ON
2003 - Zelos Therapeutics, Ottawa, ON
2003 - Zinc Therapeutics, Toronto, ON
*From 2001 -2007 this award was called the "Promising Early Stage Company(s) Recognition".

Contribution to the Association  

2009 - Dr. Lesia Babiak, Janssen-Ortho Inc.
2008 - Deborah Brown, EMD Serono
2007 - Bob Ingratta, Vice President of Regulatory & International Affairs, Monsanto Canada and Chair, BIOTECanada Agriculture & Nutrition Advisory Board
2007 - Christian Blouin, Director, Vaccine Division, Merck Frosst Canada and Chair, BIOTECanada Vaccine Industry Committee
2006 - Dr. Luis Barreto, Vice-President of Public Policy, Sanofi Pasteur  
2005 - John Mendlein, President & CEO, Affinium Pharmaceuticals (former)
2004 - Paul Hastings, President and CEO, QLT Inc.
2003 - Brian Kerslake, Senior Marketing Manager, VWR International
2002 - Claude-André Lachance, Director of Public Policy, Dow Chemicals Canada and Myka Osinchuck, (former) Executive Director, BioAlberta
2001 - Art Stirling, Government & Industry Relations Manager, Pioneer Hi-Bred Limited*
* Award  for Contribution to the Industry - combined with Contribution to Advancing the Benefits of Biotech for Canadians in 2002.